{"id":"https://openalex.org/W2082223975","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","title":"Stimulation of 5\u2010HT 1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats","display_name":"Stimulation of 5\u2010HT 1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats","publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2082223975","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","mag":"2082223975","pmid":"https://pubmed.ncbi.nlm.nih.gov/8922726","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1915949"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1996.tb15745.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15745.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15745.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046440986","display_name":"Marco Gariboldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Gariboldi","raw_affiliation_strings":["Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy","Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022761689","display_name":"Piotr Tutka","orcid":"https://orcid.org/0000-0001-5731-4295","observed_orcids":["https://orcid.org/0000-0001-5731-4295"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Piotr Tutka","raw_affiliation_strings":["Department of Pharmacology, University of Lublin, Lublin, Poland","Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Lublin, Lublin, Poland","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024725169","display_name":"ROSARIO SAMANIN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosario Samanin","raw_affiliation_strings":["Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070101998","display_name":"Annamaria Vezzani","orcid":"https://orcid.org/0000-0003-0573-6175","observed_orcids":["https://orcid.org/0000-0003-0573-6175"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Annamaria Vezzani","raw_affiliation_strings":["Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuropharmacology, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070101998"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.8353,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.70888598,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"119","issue":"5","first_page":"813","last_page":"818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/8-oh-dpat","display_name":"8-OH-DPAT","score":0.8870000243186951},{"id":"https://openalex.org/keywords/kainic-acid","display_name":"kainic acid","score":0.7990000247955322},{"id":"https://openalex.org/keywords/limbic-seizures","display_name":"limbic seizures","score":0.9679999947547913},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/dorsal-hippocampus","display_name":"dorsal hippocampus","score":0.902999997138977},{"id":"https://openalex.org/keywords/postsynaptic-receptors","display_name":"postsynaptic receptors","score":0.6349999904632568},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.9509999752044678},{"id":"https://openalex.org/keywords/seizure-latency","display_name":"seizure latency","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2776108384","wikidata":"https://www.wikidata.org/wiki/Q390239","display_name":"Kainic acid","level":4,"score":0.9528930187225342},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6043140888214111},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5865327715873718},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5779504179954529},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5394651889801025},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.5285540819168091},{"id":"https://openalex.org/C2776238416","wikidata":"https://www.wikidata.org/wiki/Q4644282","display_name":"8-OH-DPAT","level":5,"score":0.4772738814353943},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.4735221862792969},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.4633626639842987},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44892004132270813},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.4353456199169159},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39502525329589844},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.37868839502334595},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3465741276741028},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3419575095176697},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.3287762701511383},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29811811447143555},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2460412085056305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20862513780593872}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007608","descriptor_name":"Kainic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017371","descriptor_name":"8-Hydroxy-2-(di-n-propylamino)tetralin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1996.tb15745.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15745.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8922726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8922726","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1915949","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1915949/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1996.tb15745.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15745.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15745.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2082223975.pdf","grobid_xml":"https://content.openalex.org/works/W2082223975.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1930212536","https://openalex.org/W1966335977","https://openalex.org/W1966674467","https://openalex.org/W1968662228","https://openalex.org/W1969837937","https://openalex.org/W1971547290","https://openalex.org/W1978402439","https://openalex.org/W1980762519","https://openalex.org/W1984808800","https://openalex.org/W1989911024","https://openalex.org/W2013454124","https://openalex.org/W2016983964","https://openalex.org/W2018180458","https://openalex.org/W2021665391","https://openalex.org/W2024600670","https://openalex.org/W2024699900","https://openalex.org/W2024945446","https://openalex.org/W2035623153","https://openalex.org/W2040798945","https://openalex.org/W2047193867","https://openalex.org/W2064742857","https://openalex.org/W2064873959","https://openalex.org/W2065095084","https://openalex.org/W2067917778","https://openalex.org/W2068019023","https://openalex.org/W2069499214","https://openalex.org/W2070619325","https://openalex.org/W2072182596","https://openalex.org/W2081664076","https://openalex.org/W2083567291","https://openalex.org/W2087786917","https://openalex.org/W2089004632","https://openalex.org/W2092700031","https://openalex.org/W2092934228","https://openalex.org/W2094526136","https://openalex.org/W2094569992","https://openalex.org/W2256459958","https://openalex.org/W2320058521","https://openalex.org/W2327844818","https://openalex.org/W2397510385","https://openalex.org/W2409568686"],"related_works":["https://openalex.org/W2106302219","https://openalex.org/W1968662228","https://openalex.org/W1991127697","https://openalex.org/W2041427680","https://openalex.org/W2043949690","https://openalex.org/W2976141192","https://openalex.org/W2069317256","https://openalex.org/W1981749670","https://openalex.org/W2051409998","https://openalex.org/W2019521957"],"abstract_inverted_index":{"1.":[0],"We":[1],"studied":[2],"whether":[3],"the":[4,33,49,71,82,103,139,145,166,211,214,225,228,242],"stimulation":[5,236],"of":[6,26,32,60,85,102,129,142,165,186,231,244],"5-HT1A":[7,15,206,222],"receptors":[8,223],"by":[9,23,77,87,151,155,173,195],"8-hydroxy-2-(di-n-propylamino)":[10],"tetralin":[11],"(8-OH-DPAT),":[12],"a":[13,57,204],"specific":[14],"receptor":[16,207],"agonist,":[17],"reduced":[18,70,138],"electroencephalographic":[19],"(EEG)":[20],"seizures":[21,76,86,143,149],"induced":[22,150],"intrahippocampal":[24,152],"injection":[25],"0.04":[27],"microgram":[28,116,119,201],"in":[29,38,75,148,210,224,241],"0.5":[30],"microliter":[31],"glutamate":[34],"analogue":[35],"kainic":[36,53,61,153],"acid":[37,54,154],"freely-moving":[39],"rats.":[40],"2.":[41],"Pretreatment":[42],"with":[43],"8-OH-DPAT":[44,136,187,232],"15":[45],"min":[46],"earlier":[47],"at":[48],"same":[50],"site":[51],"as":[52],"injection,":[55],"caused":[56],"dose-dependent":[58],"decrease":[59],"acid-induced":[62],"seizure":[63,105,124,168],"activity.":[64],"One":[65],"and":[66,81,92,132,144,157,175,233],"10":[67],"micrograms":[68,134,177],"significantly":[69,137,193],"total":[72,83,140,146],"time":[73,147],"spent":[74],"72%":[78],"on":[79,122,159],"average":[80],"number":[84,141],"58%":[88],"(P":[89,94,110,179],"<":[90,95,111,180],"0.01)":[91,112],"43%":[93],"0.05)":[96],"respectively.":[97],"The":[98,161,183],"latency":[99,162],"to":[100,163],"onset":[101,164],"first":[104,167],"was":[106,120,169,192],"increased":[107],"2.8":[108],"times":[109,172],"only":[113],"after":[114],"1":[115,200],"8-OH-DPAT;":[117],"0.1":[118],"ineffective":[121],"all":[123],"parameters.":[125],"3.":[126],"Systemic":[127],"administration":[128],"25,":[130],"100":[131,174],"1000":[133,176],"kg-1":[135,178],"52%":[156],"74%":[158],"average.":[160],"delayed":[170],"1.8":[171],"0.05).":[181],"4.":[182],"anticonvulsant":[184,229],"action":[185,230],"given":[188],"intrahippocampally":[189],"or":[190],"systemically":[191],"blocked":[194],"5":[196],"micrograms,":[197],"but":[198],"not":[199],"WAY":[202],"100635,":[203],"selective":[205],"antagonist,":[208],"administered":[209],"hippocampus":[212,226],"before":[213],"agonist.":[215],"5.":[216],"These":[217],"results":[218],"indicate":[219],"that":[220,234],"postsynaptic":[221],"mediate":[227],"their":[235],"has":[237],"an":[238],"inhibitory":[239],"role":[240],"generation":[243],"limbic":[245],"seizures.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}